LNTH Lantheus to Buy Evergreen Theragnostics Lantheus Holdings, Inc. (NASDAQ:LNTH) announced its second acquisition this ...
In trading on Tuesday, shares of Lantheus Holdings Inc (Symbol: LNTH) crossed below their 200 day moving average of $92.96, changing hands as low as $90.75 per share. Lantheus Holdings Inc shares ...
Radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) had some news to report Tuesday morning, but the market ...
Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Invest with Confidence: ...
Lantheus (LNTH) announced the appointment of Phuong Khanh Morrow, M.D. to Lantheus’ Board of Directors, effective February 1, 2025. As an ...
Lantheus ( ($LNTH) ) has shared an update. On January 27, 2025, Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, announced an ...
The company announced a $350 million acquisition. Get Wall Street's Hottest Chart Every Morning Lantheus Holdings Inc LNTH shares are trading lower by 4.4% to $91.64 during Monday’s session ...
Lantheus Holdings Inc. is adding to its portfolio yet again, acquiring a clinical-stage radiopharmaceutical company in a deal ...
View Lantheus Holdings, Inc. (LNTH) current and estimated P/E ratio data provided by Seeking Alpha.
Massachusetts-based radiopharmaceutical company Lantheus (Nasdaq: LNTH) has announced a plan to acquire clinical-stage ...
LNTH has 3 products PLYARIFY, DEFINITY, and TechneLite, all of which are very successful. From my research, I think LTNH can easily become a $200+ stock in the next 3–5 years, which I why I'm ...